开罗制药公司癌症药物安全数据积极,股价飙升

英为财情
Jul 15, 2025

Investing.com -- 开罗制药有限公司( Kairos Pharma Ltd)(NYSE:KAPA)股价暴涨165%,此前这家临床阶段生物制药公司报告了其正在进行的ENV-105治疗转移性去势抵抗性前列腺癌患者的2期临床试验中取得积极安全性结果。 中期安全性分析表明,当与标准护理激素疗法阿帕鲁胺(apalutamide)联合使用时,ENV-105(carotuximab,一种同类首创...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10